By targeting LAMB3, the above investigations demonstrated that hsa‐mir‐133a‐2 could inhibit proliferation and invasion of cervical cancer cells, as well as the activation of the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is cervical carcinoma.